Dr.sandro Alves
Director
preclinical research
Brainvectis
France
Biography
Sandro leads the Brainvectis Preclinical Research Office and directs the preclinical activity on Alzheimer’s disease and Huntington’s disease. He is also involved in the scientific consideration of future therapeutic strategies to be developed in other neurodegenerative disorders. Prior to joining Brainvectis, Sandro conducted his research at the Brain and Spine Institute (Paris), evaluating therapeutic strategies in animal models of Spinocerebellar ataxia and then at MIRCen/CEA, developing therapeutic research in animal models of Alzheimer’s and Huntington’s disease.
Research Interest
Designing a novel drug for auto-immune diseases and make therapeutics worthy for society.
